Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208493 · ClinicalTrials.gov registry record · NA
Dietary Protein in the Very-low-birth-weight Infant
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Terminated
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01208493 is a NA study that was terminated before completion, run by Société des Produits Nestlé (SPN). The registered enrollment target is 70 participants.
The verdict
NCT01208493, a NA study, was terminated before completion, sponsored by Société des Produits Nestlé (SPN).
- TERMINATED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula. Babies will be fed the assigned formula between the time they achieve full enteral feeds and hospital discharge, for a minimum of 3 weeks. The weight gain (g/d) will be measured and compared between groups. Feeding tolerance, protein-energy status and body composition between the study groups will also be analysed. After discharge, babies will be fed a post-discharge preterm infant formula (PDF) between hospital discharge and 3 m corrected age.
Interventions
- OTHER preterm infant formula with high protein levels
- OTHER preterm standard infant formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01208493
The ClinicalTrials.gov registry entry for NCT01208493 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which preterm infant formula with high protein levels is the first listed.
NCT01208493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01208493 about?
NCT01208493 is a clinical study titled "Dietary Protein in the Very-low-birth-weight Infant". In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula. Babies will be fed the assigned formula between the time they achieve full enteral feeds and hospital discharge, for a...
What is the current status of trial NCT01208493?
This trial is currently terminated. It is a NA study. The enrollment target is 70 participants. The study started on 2007-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01208493?
The interventions under investigation include: preterm infant formula with high protein levels (OTHER), preterm standard infant formula (OTHER).
Who is sponsoring clinical trial NCT01208493?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.